Quarry Thera
Biotechnology Research • • 1-10 Employees
Company overview
| Headquarters | XX |
| NAICS | 541714 |
| Employees | 1-10 |
Key Contacts at Quarry Thera
Xin Geng
Director, Biology
Frank Comer
Senior Director
About Quarry Thera
Quarry Thera - a Biotech with a differentiated pipeline and an unprecedented platform Founded by Mikael Dolsten, MD, PhD, former CSO & RD President of Pfizer, and Professor Craig M. Crews, Ph.D. of Yale University, Quarry Thera is advancing the next generation of proximity-induced therapeutics based on molecular glues. Jeanne Magram, PhD, has recently joined the Quarry Thera team as CSO, bringing deep experience in drug discovery from leadership roles at several top pharmaceutical companies and as founding CSO of biotechs delivering therapeutics in both immunology and oncology. Molecular glues have emerged as a powerful new modality in drug development and combine proprietary DNA-encoded libraries, structurally enabled drug design, and sophisticated medicinal chemistry to address challenges with currently available therapeutic options, including sub-optimal efficacy, narrow therapeutic windows, limited cellular permeability, and selectivity challenges associated with targeting undruggable proteins. More information coming soon.
Quarry Thera revenue & valuation
| Annual revenue | $513,330 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,700,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Quarry Thera has 2 employees across 2 departments.
Departments
Number of employees
Funding Data
Quarry Thera has never raised funding before.
South Africa
Czechia
Netherlands
Frequently asked questions
4.8
40,000 users
